Skip to search formSkip to main contentSkip to account menu

efungumab

Known as: Immunoglobulin, Anti-(Candida Heat-Shock Protein Hsp 90) (Human Monoclonal Hsp90mab Fragment) 
A human single-chain variable fragment of a monoclonal antibody against fungal Hsp90 with anti-fungal activity. Efungumab binds to heat shock protein… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Monoclonal Antibodies
antigen binding

Narrower (1)

mycograb

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Heat shock protein inhibitors for the treatment of fungal infections.
Invasive fungal infections are a leading cause of mortality, especially in immunocompromised patients. Therapy is made difficult… 
2008
2008
Gateways to clinical trials. July-August 2008.
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept… 
2007
2007
ÚSPù·NÁ LÉâBA PROKÁZANÉ KANDIDOVÉ PERITONITIDY ZA POUÎITÍ EFUNGUMABU (MYCOGRAB ) U DÍTùTE S ABDOMINÁLNÍM NON-HODGKINSKM LYMFOMEM SUCCESSFUL TREATMENT OF THE PROVEN CANDIDA PERITONITIS IN CHILD WITH…
Kliaova slova: invazivni mykoza, duti, lymfom, antimykoticka terapie, monoklonalni protilatka. Summary Invasive fungal infections… 
2007
2007
Novartis faces questions over efungumab marketing refusal
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)